The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole

AIMS: Fosfluconazole is a phosphate prodrug of fluconazole (FLCZ). This study was conducted to investigate the effect of renal impairment on the pharmacokinetics of fosfluconazole and FLCZ, and to assess the safety and toleration of fosfluconazole following a single intravenous bolus injection of fo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sobue, Satoshi, Tan, Keith, Layton, Gary, Leclerc, Violette, Weil, Angelika
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2004
Gaiak:
Pharmacokinetics/Pharmacodynamics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884522/
https://ncbi.nlm.nih.gov/pubmed/15151523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2004.02073.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak